CAR-T Meeting 2020 | Building a Swiss timepiece: CAR T-cell industrial manufacturing

Name: Building a Swiss timepiece: CAR T-cell industrial manufacturing
Uploaded: 2020-01-30T00:00:00.000Z
Duration: 55 s
Description: Dorothea Ledergerber, PhD, Novartis, Stein, Switzerland, tells us how Novartis opened a new manufacturing facility for cell and gene therapies in just a year. Dr Ledergerber outlines the challenges faced in CAR T-cells manufacture, in particular, the turnaround time. This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.

Dorothea Ledergerber • 30 Jan 2020

CAR-T Meeting 2020

General CAR-T

Dorothea Ledergerber, PhD, Novartis, Stein, Switzerland, tells us how Novartis opened a new manufacturing facility for cell and gene therapies in just a year. Dr Ledergerber outlines the challenges faced in CAR T-cells manufacture, in particular, the turnaround time. This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.